Table of Contents Table of Contents
Previous Page  37 / 146 Next Page
Information
Show Menu
Previous Page 37 / 146 Next Page
Page Background

Results:

The protocol warranties a higher accuracy showing a reduced error

in patient setup after the first five treatments. Systematic errors are reduced

but differences are observed across number of fractions and different pa-

thologies. In breast treatment the vertical orientation is affected of major

errors. After the first 5 treatments the errors in all directions are signifi-

cantly reduced for every pathology.

Conclusions:

Results suggest introducing a new setup correction around

the 20th treatment in order to maintain the error in patient setup under

4 mm. The protocol reduce the systematic error in all pathology treated

and warranty a reduction of 44% of CB CT’s, reducing the imaging dose (in

the longest treatment as prostate, from 750 mSv to 420 mSv) and CB time

by the same percentage.

http://dx.doi.org/10.1016/j.ejmp.2016.01.110

A.107

CATALYST SYSTEM IN BREAST CANCER RADIATION THERAPY: FEASIBILITY

STUDY AND PERFORMANCE ASSESSMENT

M. Haller

* , a ,

S. Hofer

a ,

P. Ferrari

a ,

M. Maffei

b .

a

Azienda Sanitaria dell’Alto

Adige – Servizio Aziendale di Fisica Sanitaria, Bolzano, Italy;

b

Azienda Sanitaria

dell’Alto Adige – Servizio di Radioterapia Oncologica del Comprensorio Sanitario

di Bolzano, Bolzano, Italy

Introduction:

The patient positioning standard procedure in the Radia-

tion Therapy Department in Bolzano during breast cancer treatment was

based on iViewGTTM (Elekta AB, Stockholm, Schweden) orthogonal fields

EPID acquisition. The patient was centred using marker draws on skin and

position checked by iViewGT acquisition. The proposed study is a retro-

spective analysis to assess the performance of the new technology

CatalystTM-System (C-RAD AB, Schweden) aiming to substitute the draws

on patient in the positioning procedure and limiting the numbers of the

iViewGTTM. We compare the CatalystTM positioning versus draws on skin

positioning observing the numbers of false-negative and comparing the po-

sitioning errors. The new equipment is less time consuming during the

positioning given an on line feedback of the patient position.

Material and Methods:

Two groups of patients are considered. 1236 patient

are positioned with draws and 589 patients with CatalystTM. Every patient

position in both groups was verified by iViewTM orthogonal fields EPID ac-

quisition, in order to identify the false negative and the relative error. Percent

of false-negative, standard deviation and mean in the three orientations

were calculated and compared respectively between the two groups. T-test

was used to compare intra-group standard deviation.

Results:

Results showed comparable efficacy of the new procedure

CatalystTM versus the draws positioning with a percentage of false-

negative equal to 12%. Position errors are comparable in longitudinal and

lateral direction and significantly (p

<

1.08E

6) reduced in vertical direc-

tion of 50% using CatalystTM.

Conclusions:

The new equipment CatalystTM can be considered an im-

provement in patient position during breast cancer radiation therapy,

warranting a comparable efficacy respect the standard procedure, improve

the precision in vertical direction and results to more practice, time-

saving and warranting an on line feedback in the patient position limiting

the errors during treatment.

http://dx.doi.org/10.1016/j.ejmp.2016.01.111

A.108

DOSIMETRIC COMPARISON BETWEEN FOUR IRRADIATION TECHNIQUES

FOR BREAST CANCER

M. Iacco

* , a ,

C. Zucchett

i a ,

M. Marcantonini

a ,

A.C. Dipilat

o a ,

V. Lancellott

a b ,

C. Aristei

b ,

R. Tarducci

a .

a

Medical Physics Department, Santa Maria della

Misericordia Hospital, Perugia, Italy;

b

Radiation Oncology Department, Santa

Maria della Misericordia Hospital, Perugia, Italy

Introduction:

The purpose of this work was to compare the dosimetric

results of treatment plans using 3D Conventional Radiation Therapy (3DCRT),

Intensity Modulated Radiation Therapy (IMRT) linac-based, with Helical

Tomotherapy (HT) and Direct Tomotherapy (DT) in breast cancer pa-

tients, who required irradiation of the chest wall/breast and draining nodes.

Materials and Methods:

30 breast cancer patients (17 right, 13 left) were

enrolled. Four plans (3DCRT, IMRT linac-based, HT and DT) were created

for each patient. Dose prescription was 50 Gy in 25 fractions to the PTV

retracted 2 mm from the skin (PTV eval).

Results:

Plans were compared in terms of doses to the PTV, homogeneity

index (HI) and doses to OARs. The non-parametric Friedman test for paired

data and the Conover post-hoc analysis were used to compare the differ-

ent irradiation techniques. D98%, D95%, D50% and mean doses (Dmean) of

target increased significantly for IMRT techniques particularly for

tomotherapy treatments. HI was significantly higher for HT, compared with

the other techniques. V5 Gy and V20 Gy of the ipsilateral lung and V5 Gy

of the contralateral lung increased significantly with the IMRT tech-

niques. The heart received significantly lower mean and maximum doses

(D2%) with 3DCRT for right-sided treatments; significantly lower D2% and

V25 Gy of heart results were achieved with HT techniques in left-sided treat-

ments, but the Dmean was higher. The contralateral breast was better spared

with 3DCRT.

Conclusions:

IMRT techniques significantly improved the HI and the

minimum doses to the target. However, this result was achieved at the cost

of a greater exposure of all OARs (lungs, heart in right-sided and left-

sided treatment and contralateral breast) to low and medium doses. With

regard to left-sided treatments, HT resulted to be the better performing

technique for the sparing of the heart.

http://dx.doi.org/10.1016/j.ejmp.2016.01.112

A.109

PRE-TREATMENT DQA USING ARCCHECK FOR CRANIOSPINAL

IRRADIATION WITH HELICAL TOMOTHERAPY

G. Iacoviello

*

, B.F. Abbate, V. Caputo, F. D’Alia, K.K. Gallias, M. Spano’.

ARNAS

– Ospedale Civico – UOC Fisica Sanitaria, Palermo, Italy

Introduction:

The aim of this work is to analyze two pre-treatment dose

verification methods using the ArcCheck diode array for craniospinal ir-

radiation (CSI) with helical tomotherapy (HT).

Materials and Methods:

The Sun Nuclear diode array, ArcCheck, is a cy-

lindrical acrylic phantom that can be used for dose verification of fields

up to 20 cm. Some radiotherapy techniques, however, as craniospinal ir-

radiation or total marrow irradiation, require fields longer than 20 cm. To

overcome this limitation, we followed a double procedure. In the first one

we split the verification plan in two DQA plans, calculated at the head level

and at the middle dorso-lumbar level, on two different kVCT Data Set of

ArcCheck obtained with the phantom oriented with electronics toward gun

and toward target respectively. In the second one we calculated one single

DQA plan on a virtual CT of a longer ArcCheck (50 cm), downloaded from

the Sun Nuclear Support web page, delivered in two steps with different

ArcCheck orientation and then analysed using the merging function in the

SNC Patient software. In both cases the DQA plans were created with “fine”

grid calculation and with the PMMA ArcCHECK cavity insert.

Results:

The comparison between calculated and measured dose was per-

formed in 3D Absolute Dose Mode on 15 DQA plans with a 3%/3 mm gamma

analysis criterion according to Van Dyk with a 10% threshold. The average

gamma passing rate for splitted DQA plans was 99.1%

±

0.8% (range 99.7–

98.3%) for the head region and 99.4%

±

0.4% (range 99.8–99.1%) for the dorso-

lumbar region. For the single DQA plan we obtained 97.1%

±

0.6% (range

96.1–97.5%).

Conclusions:

In our institution a DQA plan is accepted if 95% of the points

“pass” the 3%–3 mm gamma evaluation criterion and this result has been

obtained for both methodologies. Due to limited number of cases we cannot

assess any statistical difference between the two methods.

http://dx.doi.org/10.1016/j.ejmp.2016.01.113

A.110

CLINICAL IMPLICATIONS AFTER A CHANGE IN THE DOSE CALCULATION

ALGORITHM IN VMAT TREATMENTS OF NASOPHARYNGEAL TUMORS

A. Ianiro

* , a ,

F. Deodato

a ,

G. Macchia

a ,

C. Digesu

a ,

P. Viola

a ,

M. Craus

a ,

M. Ferro

a ,

V. Picardi

a ,

M. Nuzzo

a ,

A. Piermattei

b ,

V. Valentini

b ,

A.G. Morgant

i c ,

S. Cilla

a .

a

Fondazione di Ricerca e Cura Giovanni Paolo II-

Università Cattolica del S. Cuore, Campobasso, Italy;

b

Policiinico Universitario

A. Gemelli – Università Cattolica del S. Cuore, Roma, Italy;

c

DIMES Università

di Bologna – Ospedale S.Orsola Malpighi, Bologna, Italy

e32

Abstracts/Physica Medica 32 (2016) e1–e70